Fulton Bank
VRTX icon

Fulton Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Fulton Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$422K Sell
807
-180
-18% -$92.2K 0.01% 502
2026
Q2 		$490K Buy
987
+82
+9% +$36.3K 0.02% 495
2026
Q1 		$404K Sell
905
-22
-2% -$10.3K 0.01% 496
2025
Q4 		$420K Sell
927
-97
-9% -$41.8K 0.01% 481
2025
Q3 		$401K Buy
1,024
+177
+21% +$74K 0.01% 482
2025
Q2 		$377K Buy
847
+274
+48% +$126K 0.01% 486
2025
Q1 		$278K Sell
573
-180
-24% -$83.9K 0.01% 549
2024
Q4 		$303K Sell
753
-45
-6% -$20.9K 0.01% 536
2024
Q3 		$371K Sell
798
-120
-13% -$57.6K 0.01% 499
2024
Q2 		$430K Sell
918
-3,146
-77% -$1.37M 0.02% 423
2024
Q1 		$1.7M Sell
4,064
-44
-1% -$18.6K 0.07% 204
2023
Q4 		$1.67M Buy
4,108
+59
+1% +$21.8K 0.08% 196
2023
Q3 		$1.41M Sell
4,049
-50
-1% -$17.5K 0.07% 207
2023
Q2 		$1.44M Sell
4,099
-631
-13% -$213K 0.07% 201
2023
Q1 		$1.49M Buy
4,730
+104
+2% +$31.2K 0.08% 193
2022
Q4 		$1.34M Sell
4,626
-3
-0.1% -$914 0.08% 195
2022
Q3 		$1.34M Sell
4,629
-312
-6% -$89.8K 0.08% 188
2022
Q2 		$1.39M Buy
4,941
+643
+15% +$172K 0.08% 183
2022
Q1 		$1.12M Buy
+4,298
New +$1.02M 0.05% 225
2021
Q1 		– Sell
-4,640
Closed -$1.1M – 500
2020
Q4 		$1.1M Buy
4,640
+257
+6% +$59K 0.06% 202
2020
Q3 		$1.19M Buy
4,383
+1,223
+39% +$337K 0.07% 173
2020
Q2 		$917K Buy
+3,160
New +$857K 0.06% 206

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Fulton Bank's VRTX Position: Q3 2026 in Review

Fulton Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 18% in Q3 2026, selling an estimated $92.2K and leaving 807 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #502.

Fulton Bank first reported a position in VRTX in Q2 2020 and has held it in 22 quarters since. The position peaked at $1.7M in Q1 2024. 315 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Fulton Bank held 807 shares of Vertex Pharmaceuticals worth $422K as of Q3 2026.
  • Fulton Bank sold 180 Vertex Pharmaceuticals shares in Q3 2026, an estimated $92.2K.
  • Vertex Pharmaceuticals made up 0.01% of Fulton Bank's portfolio in Q3 2026, its #502 holding.
  • Fulton Bank first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 22 quarters since.
  • Fulton Bank's Vertex Pharmaceuticals position peaked at $1.7M in Q1 2024.
  • 315 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Fulton Bank's 13F filing for Q3 2026, filed 14 Oct 2026.